Not intended for U.S. and UK Media — Bayer to Highlight New Oncology Research at ASH 2017 — New data include further safety and efficacy follow-up from the CHRONOS-1 study in indolent non-Hodgkin’s lymphoma (for specialized target groups only)

Bayer press release – Not intended for U.S. and UK Media — Bayer to Highlight New Oncology Research at ASH 2017 — New data include further safety and efficacy follow-up from the CHRONOS-1 study in indolent non-Hodgkin’s lymphoma (for specialized target groups only)

Continue reading at the original source >>